MYC and breast cancer: Kim et al. (2017) identified c-MYC as a direct target of Usp22 deubiquitinating activity and reasoned that Usp22 overexpression stimulated breast cancer cell line growth and colony formation through the increased tumorigenic activity of c-MYC [34].